| Income Statement |
| Operating Expenses | 1.94M |
|
| Research and Development Expense | 811.84K |
| Selling, General and Administrative Expense | 1.13M |
| Operating Income | -1.94M |
| Net Income | -1.92M |
| Net Income Common Stock | -1.92M |
| Net Income Common Stock (USD) | -1.92M |
| Consolidated Income | -1.92M |
| Earnings per Basic Share | -1.95 |
| Earnings per Basic Share (USD) | -1.95 |
| Earnings per Diluted Share | -1.95 |
| Earning Before Interest & Taxes (EBIT) | -1.92M |
| Earning Before Interest & Taxes (USD) | -1.92M |
| Weighted Average Shares | 984.67K |
| Weighted Average Shares Diluted | 984.67K |
| Balance Sheet |
| Cash and Equivalents | 3.68M |
| Cash and Equivalents (USD) | 3.68M |
| Current Assets | 3.97M |
| Property, Plant & Equipment Net | 1.62M |
| Total Assets | 5.60M |
| Debt Current | 97.03K |
| Total Debt | 97.03K |
| Current Liabilities | 1.41M |
| Total Liabilities | 1.42M |
| Accumulated Retained Earnings (Deficit) | -43.44M |
| Shareholders Equity | 4.18M |
| Shareholders Equity (USD) | 4.18M |
| Assets Non-Current | 1.63M |
| Total Debt (USD) | 97.03K |
| Liabilities Non-Current | 3.49K |
| Trade and Non-Trade Payables | 220.29K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 49.56K |
| Net Cash Flow from Financing | 124.10K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.48M |
| Capital Expenditure | -15.31K |
| Issuance (Purchase) of Equity Shares | 125.15K |
| Issuance (Repayment) of Debt Securities | -1.05K |
| Net Cash Flow from Investing | -15.31K |
| Net Cash Flow from Operations | -1.59M |